Leaders

In the Aerospace, transport and defense & security segments

Thanks to all its growth, competitiveness, and people initiatives, Thales is undergoing a profound transformation which will foster profitable and sustainable growth.

2016 key figures
€bn 33.5Order book
€bn 16.5Order intake

€bn 14.9Sales
€m 1,354Ebit

Registration document

2016
Registration Document
Download

Latest financial release

H1 2017
Download

Past financial results

  • 26/07/2017
    Half Year 2017 results
  • 03/05/2017
    Order intake and sales at 31 March 2017
  • 28/02/2017
    Full-year 2016 results
  • 19/10/2016
    Order intake and sales at 30 September 2016

Upcoming Events

  • 19/10/2017
    Order intake and sales at 30 September 2017
  • 06/03/2018
    Full -Year 2017 results
  • 23/05/2018
    Annual General Meeting
  • Thales Group - Generic_Thales_diagonal
    26 Jul 2017
    2017 Half-year results
    Patrice Caine, Chairman and Chief Executive Officer, commented: “At the end of June, Thales is once again confirming its growth momentum, with a solid order intake and a 5.9% organic sales growth, ahead of the full year target.
  • Thales Group - Thales generic
    03 May 2017
    Q1 2017 order intake and sales
    Patrice Caine, Chairman and Chief Executive Officer, commented: "The start of 2017 has confirmed the solid momentum of all of our businesses, with organic sales growth ahead of the full year target, driven by both mature and emerging markets [...]
  • Thales Group - Generic_Thales_diagonal
    28 Feb 2017
    2016 Full-Year results
    Patrice Caine, Chairman & Chief Executive Officer, stated:  “2016 represents another successful milestone for our profitable growth strategy. [...]
  • Thales generic show
    19 Oct 2016
    Order intake and sales at 30 September 2016
    Patrice Caine, Chairman & Chief Executive Officer, commented: "Over the first nine months of the year, thanks to the efforts of its employees across the globe, Thales posted a solid commercial momentum, including a sharp rise in order intake in its aerospace and defence segments.
Contact
Investor Relations
+33 (0) 1 57 77 89 02